I have been working in DNA damage repair labs, where the main focus was to find mechanisms of drug resistance and novel therapies to target cancers with defects in DNA repair.
My last work experience was at the Institut Curie in Paris, where I have been working since 2017 in a lab specializing in DNA damage repair. Here, I have been working on a project that describes a novel therapy to target BRCA1/2-deficient cancers.
I will be working on a project to map mutations in the non-coding genome to the type of cancer it gives rise to.